www.rsc.org/chemistryworld/2016/01/gene-editing-crispr-commercial
www.scientificamerican.com/article/money-from-genes-crispr-goes-commercial/
firstround.com/review/the-30-best-pieces-of-advice-for-entrepreneurs-in-2015/
CRISPR Dispute to Be Decided by Patent Office | MIT Technology Review [...]
VC Deals (16 deals, $330M invested) Zai Labs, a Shanghai-based drug developer whose lead candidate is focused on treating liver cancer, has raised more than $100 million in Series B funding. [...]
mobihealthnews.com/content/top-5-predictions-2016-health-tech-and-services
[...]
[...]
Microbiome analysis: How one tech company is changing health behaviors, one fecal sample at a time – TechRepublic
0 0
http://www.techrepublic.com/article/microbiome-analysis-how-one-tech-company-is-changing-health-behaviors-one-fecal-sample-at-a-time/
http://www.nextbigwhat.com/indian-startups-2015-297/